3D/4D Functional Imaging of Tumor-Associated Proteolysis

Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Methods in enzymology (Impact Factor: 2.09). 01/2012; 506:175-94. DOI: 10.1016/B978-0-12-391856-7.00034-2
Source: PubMed


Proteases play causal roles in many aspects of the aggressive phenotype of tumors, yet many of the implicated proteases originate from tumor-associated cells or from responses of tumor cells to interactions with other cells. Therefore, to obtain a comprehensive view of tumor proteases, we need to be able to assess proteolysis in tumors that are interacting with their microenvironment. As this is difficult to do in vivo, we have developed functional live-cell optical imaging assays and 3D and 4D (i.e., 3D over time) coculture models. We present here a description of the probes used to measure proteolysis and protease activities, the methods used for imaging and analysis of proteolysis and the 3D and 4D models used in our laboratory. Of course, all assays have limitations; however, we suggest that the techniques discussed here will, with attention to their limitations, be useful as a screen for drugs to target the invasive phenotype of tumors.

Download full-text


Available from: Bonnie F Sloane, Sep 29, 2015
1 Follower
22 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Our laboratory has had a longstanding interest in how the interactions between tumors and their microenvironment affect malignant progression. Recently, we have focused on defining the proteolytic pathways that function in the transition of breast cancer from the pre-invasive lesions of ductal carcinoma in situ (DCIS) to invasive ductal carcinomas (IDCs). We use live-cell imaging to visualize, localize and quantify proteolysis as it occurs in real-time and thereby have established roles for lysosomal cysteine proteases both pericellularly and intracellularly in tumor proteolysis. To facilitate these studies, we have developed and optimized 3D organotypic co-culture models that recapitulate the in vivo interactions of mammary epithelial cells or tumor cells with stromal and inflammatory cells. Here we will discuss the background that led to our present studies as well as the techniques and models that we employ. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.
    Biochimica et Biophysica Acta 08/2011; 1824(1):123-32. DOI:10.1016/j.bbapap.2011.07.025 · 4.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cell culture is among the most utilized techniques in biomedical research. The ability to grow mammalian cells in a dish has provided researchers with a tool to study the many mechanisms of biological function. The in vivo interactions in which cells participate, such as extracellular matrix adhesion, breakdown and deposition, along with cell to cell communications are key processes that need to be understood. Three-dimensional (3-D) cell culture has proved amenable to analysis of these interactions. Therefore, we have established a 3-D culture system, which utilizes co-culture of human breast epithelial cells with tumor-associated cells such as macrophages and/or fibroblasts. This unique 3-D model, which we have designated Mammary Architecture and Microenvironment Engineering or MAME, allows us to examine cellular function and mechanisms in a context more comparable to the in vivo microenvironment. In addition, we are able to visualize dynamic cellular processes such as proteolysis and invasion as they occur over time. In this manner we have taken cell cultures from 2-D to a multifaceted 4-D setting.
    Breast Cancer Metastasis and Drug Resistance, 01/2013: pages 177-188; , ISBN: 978-1-4614-5646-9
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The genetic reprogramming technology allows one to generate pluripotent stem cells for individual patients. These cells, called induced pluripotent stem cells (iPSCs), can be an unlimited source of specialized cell types for the body. Thus, autologous somatic cell replacement therapy becomes possible, as well as the generation of in vitro cell models for studying the mechanisms of disease pathogenesis and drug discovery. Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder that leads to a loss of upper and lower motor neurons. About 10% of cases are genetically inherited, and the most common familial form of ALS is associated with mutations in the SOD1 gene. We used the reprogramming technology to generate induced pluripotent stem cells with patients with familial ALS. Patient-specific iPS cells were obtained by both integration and transgene-free delivery methods of reprogramming transcription factors. These iPS cells have the properties of pluripotent cells and are capable of direct differentiation into motor neurons.
    Acta Naturae 04/2014; 6(1):54-60. · 1.00 Impact Factor
Show more